What Most Doctors Never Explain About EDS | Office Hours (Ep 204)
About this episode
Dr. Linda Bluestein answers common questions about Ehlers-Danlos syndromes and related conditions in a listener Q&A format.
If you could listen to just one conversation about Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS), what would you need to know? In this listener Q&A episode, producer Aron Korney puts host Dr. Linda Bluestein, the Hypermobility MD, in the hot seat to answer the questions patients ask most about hypermobility, connective tissue disorders, genetic testing, medications, and managing complex chronic illness. Dr. Bluestein explains why EDS, HSD, POTS, and MCAS are whole-body conditions rather than isolated joint disorders, and how connective tissue affects nearly every organ system. She shares why "less is more," why small, consistent improvements create meaningful long-term progress, and how the placebo and nocebo effects can influence healing. The conversation also covers the U.S. Food and Drug Administration (FDA) black box warning for fluoroquinolone antibiotics, including ciprofloxacin, levofloxacin, and moxifloxacin, explaining why people with connective tissue disorders should discuss safer alternatives with their healthcare providers when appropriate. Dr…
More episodes of Bendy Bodies with Dr. Linda Bluestein
- The Hidden Link Between Long COVID, Lyme Disease & Hypermobility with Dr. Ina Stephens (Ep 205)
- Why Small Wins Matter More Than Miracle Cures in EDS and HSD: The MENS-PMMS Method™ with Dr. Dacre Knight (Ep 203)
- EDS Information Overload: How to Know What to Trust | Ep. 202
- Physical Therapy for EDS: Why It Fails and How to Make It Work | Ep. 201
Explore listener stats, chart rankings, contacts and more on the Bendy Bodies with Dr. Linda Bluestein podcast page.